Kathryn E. Falberg

Companies

• Nuvation Bio Inc.Board member Feb 12, 2021 to now¹
• Arcus BiosciencesBoard member Mar 14, 2018 to now²
• Trade DeskBoard member Sep 20, 2016 to now³
• TricidaBoard member Jun 27, 2018 to Jun 16, 2022⁴
• UroGen Pharma Ltd.Board member Jan 10, 2019 to Jun 9, 2021⁵
• Aimmune Therapeutics (United Kingdom)Board member Aug 5, 2015 to Oct 14, 2020⁶
• Sio Gene Therapies Inc.Board member Apr 11, 2017 to May 16, 2017⁷
• MedivationBoard member Feb 4, 2013 to Sep 30, 2016⁸
• BioMarin PharmaceuticalBoard member Jul 19, 2016 to Sep 1, 2016⁹
• aTyr PharmaBoard member May 6, 2015 to May 26, 2016¹⁰
• Halozyme TherapeuticsBoard member May 17, 2007 to May 6, 2016¹¹
• Jazz PharmaceuticalsChief financial officer Dec 9, 2009 to Mar 6, 2014¹²
• Oruka Therapeutics, Inc.Chief financial officer Mar 3, 2009 to Jun 26, 2009¹³
• Oruka Therapeutics, Inc.Chief operating officer Mar 3, 2009 to Jun 26, 2009¹³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABArcus Biosciences RCUS176,406 shares¹⁴$3.8M at $21.66Jun 12, 2026
• NBNuvation Bio Inc. NUVB250,000 shares¹⁵$1.1M at $4.45Dec 5, 2022
• Trade Desk TTD0 shares¹⁶Mar 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2026Granted 5,700 shares of Arcus Biosciences¹⁴
• Mar 23, 2026Returned to company 212 shares at $59.17 of Trade Desk¹⁶
• Mar 23, 2026Returned to company 296 shares at $59.17 of Trade Desk¹⁶
• Mar 23, 2026Returned to company 212 shares at $59.17 of Trade Desk¹⁶
• Mar 23, 2026Returned to company 1,226 shares of Trade Desk¹⁶
• Mar 5, 2026Sold 50,000 shares at $30.48 of Trade Desk¹⁷
• Mar 5, 2026Sold 102,828 shares at $30.45 of Trade Desk¹⁷
• Jun 10, 2025Granted 13,300 shares of Arcus Biosciences¹⁸
• May 27, 2025Granted 845 shares at $59.17 of Trade Desk¹⁹
• May 27, 2025Granted 1,183 shares at $59.17 of Trade Desk¹⁹
• May 27, 2025Granted 845 shares at $59.17 of Trade Desk¹⁹
• May 27, 2025Granted 4,901 shares of Trade Desk¹⁹
• Apr 15, 2025Granted 90 shares at $63.73 of Trade Desk²⁰
• Aug 13, 2024Sold 150,000 shares at $98.17 of Trade Desk²¹
• Jun 6, 2024Granted 8,400 shares of Arcus Biosciences²²
• May 28, 2024Granted 573 shares at $87.16 of Trade Desk²³
• May 28, 2024Granted 573 shares at $87.16 of Trade Desk²³
• May 28, 2024Granted 3,155 shares of Trade Desk²³
• Mar 8, 2024Sold 95 shares at $82.36 of Trade Desk²⁴
• Mar 8, 2024Sold 102,935 shares at $81.90 of Trade Desk²⁴
• Mar 8, 2024Converted 103,030 shares at $1.80 of Trade Desk²⁴
• Jun 15, 2023Granted 6,800 shares of Arcus Biosciences²⁵
• Jun 15, 2023Gift 50,504 shares of Arcus Biosciences²⁵
• May 25, 2023Granted 799 shares at $62.52 of Trade Desk²⁶
• May 25, 2023Granted 799 shares at $62.52 of Trade Desk²⁶